CRIS Current Research Information System

FESTI, DAVIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.471
EU - Europa 7.303
AS - Asia 3.898
AF - Africa 478
SA - Sud America 29
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 23.191
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.436
GB - Regno Unito 2.127
CN - Cina 1.344
IT - Italia 1.251
SG - Singapore 1.060
SE - Svezia 1.012
DE - Germania 985
VN - Vietnam 799
IN - India 469
UA - Ucraina 395
IE - Irlanda 372
RU - Federazione Russa 278
FR - Francia 272
ZA - Sudafrica 173
EE - Estonia 164
CH - Svizzera 135
TG - Togo 112
BG - Bulgaria 92
CI - Costa d'Avorio 79
JO - Giordania 79
NG - Nigeria 69
FI - Finlandia 54
SC - Seychelles 42
GR - Grecia 34
BE - Belgio 28
CA - Canada 27
NL - Olanda 27
JP - Giappone 23
IR - Iran 22
PL - Polonia 20
ID - Indonesia 18
PK - Pakistan 18
KR - Corea 15
BR - Brasile 11
LB - Libano 11
AT - Austria 9
CL - Cile 9
HR - Croazia 9
AU - Australia 8
CZ - Repubblica Ceca 8
ES - Italia 7
MX - Messico 7
TR - Turchia 7
HK - Hong Kong 6
BD - Bangladesh 5
PT - Portogallo 5
EC - Ecuador 4
RO - Romania 4
AL - Albania 3
DK - Danimarca 3
IQ - Iraq 3
PE - Perù 3
RS - Serbia 3
AR - Argentina 2
EG - Egitto 2
IL - Israele 2
KZ - Kazakistan 2
LT - Lituania 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SA - Arabia Saudita 2
TH - Thailandia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
EU - Europa 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
UG - Uganda 1
UZ - Uzbekistan 1
Totale 23.191
Salva come PNG Salva come JPEG
Città #
Southend 1.966
Fairfield 1.763
Chandler 1.064
Singapore 950
Ashburn 850
Woodbridge 604
Seattle 586
Santa Clara 577
Houston 552
Wilmington 538
Princeton 474
Cambridge 452
Dong Ket 398
Dublin 372
Ann Arbor 366
Boardman 302
Bologna 259
Jacksonville 231
Nanjing 198
Westminster 192
Padova 156
New York 149
Berlin 127
Lomé 112
Bern 108
Saint Petersburg 102
Medford 100
San Diego 96
Sofia 89
Jinan 83
Milan 82
Abidjan 79
Amman 79
Beijing 73
Shenyang 70
Abeokuta 69
Dearborn 67
Turin 66
Bremen 65
Changsha 60
Hebei 57
Des Moines 53
Frankfurt am Main 53
Helsinki 53
Nanchang 50
Florence 48
Redwood City 46
Tianjin 46
Guangzhou 44
Jiaxing 43
Mahé 41
Rome 40
Mülheim 36
Shanghai 36
Los Angeles 32
Redmond 31
Norwalk 29
Brussels 27
Pune 26
Washington 26
Zhengzhou 26
Falls Church 24
Ningbo 22
Hangzhou 21
Taizhou 21
Mountain View 19
Kuban 18
Kunming 18
Fuzhou 17
Haikou 17
Tokyo 17
Lanzhou 16
Shenzhen 16
Verona 16
Jakarta 15
Leawood 15
Olalla 15
Toronto 15
Bühl 14
Wuhan 14
London 13
Hyderabad 12
Taiyuan 12
Xi'an 12
Groningen 11
Phoenix 11
Chengdu 10
Monmouth Junction 10
San Francisco 10
Torino 10
Trieste 10
Frankfurt Am Main 9
Modena 9
Trento 9
Boydton 8
Chongqing 8
Forlì 8
Hefei 8
Kyiv 8
Paris 8
Totale 15.895
Salva come PNG Salva come JPEG
Nome #
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 219
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 210
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 202
Ablation for hepatocellular carcinoma: beyond the standard indications 199
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 186
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. 184
Clinical application of faecal calprotectin in ulcerative colitis patients 179
null 179
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 175
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. 172
Adverse Food Reaction and Functional Gastrointestinal Disorders: Role of the Dietetic Approach 168
The aetiology of chronic hepatitis in Italy: Results from a multicentre national study 166
Correlazione materno-fetale degli acidi biliari in corso di colestasi gravidica 162
Benign hepatic nodular lesions after treatment for childhood cancer 156
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments 154
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 151
Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension 149
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 147
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 146
Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis 146
“Are the Expanded Baveno VI Criteria really safe to screen compensated cirrhotic patients for high-risk varices?” 146
Chronic hepatitis B in Italy: New features of an old disease - Approaching the universal prevalence of hepatitis B e antigen-negative cases and the eradication of hepatitis D infection 145
"Alimentazione e salute: Strategie nutrizionali per la prevenzione delle malattie”. 19 gennaio 2006 - Oratorio San Filippo Neri – Via Manzoni, 5 - Bologna. 142
Are noninvasive methods clinically useful in advanced, decompensated liver cirrhosis when "les Jeux Sont Faits"? 142
Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis 142
Body weight,lifestyle,dietary habits and gastroesophageal reflux disease 142
G-CSF administration is not related to Peg-IFN alfa-2b treatment duration nor response in liver transplanted patients with HCV recurrence. 141
Clinical impact of sarcopenia assessment in patients with liver cirrhosis 139
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 138
Biliary symptoms, gallbladder motility, and cholecystectomy 135
Autoimmune liver diseases in a paediatric population with coeliac disease. A 10-year single-centre experience 131
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 131
Sulfasalazine in Prevention of Pouchitis After Proctocolectomy with Ileal Pouch–Anal Anastomosis for Ulcerative Colitis 130
Focal nodular hyperplasia of the liver after intensive treatment for pediatric cancer: is hematopoietic stem cell transplantation a risk factor? 128
A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naive patients with chronic hepatitis C 128
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation. 127
Gut Microbiota and Celiac Disease 127
Treatment of nonalcoholic fatty liver with focus on emerging drugs 126
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 124
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 124
Pancreatic ultrasound elastography and its clinical use in predicting the risk of pancreatic fistulas after pancreatic resection 124
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 124
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 122
Alimentazione e salute: Linee guida per il Consumatore Bolognese, 29 aprile 2004. Oratorio S.Filippo Neri, Via Manzoni, 5 - Bologna 121
Dieta e microbiota intestinale: Due facce di una stessa medaglia? 121
Management of hepatic encephalopathy: focus on antibiotic therapy 121
Corrigendum to “Differences in liver stiffness values obtained with new ultrasound elastography machines and fibroscan: A comparative study” [Dig. Liver Dis. 49 (2017) 802–808](S1590865817302463)(10.1016/j.dld.2017.03.001) 121
Plasma antioxidant enzymes and clastogenic factors as possible biomarkers of colorectal cancer risk 120
Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT 120
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients 120
Calcolosi della colecisti complicata 119
Coeliac disease and autoimmune hepatitis: Gluten-free diet can influence liver disease outcome. 119
Focal nodular hyperplasia of the liver in children after hematopoietic stem cell transplantation. 119
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 118
Regolazione dei trasportatori placentari degli acidi biliari MRP2, MRP3, MRP4 da parte dell’acido ursodesossicolico in corso di colestasi gravidica 117
Value of Transient Elastography Measured With Fibroscan in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma. 117
The importance of HCV on the burden of chronic liver disease in Italy: A multicenter prevalence study of 9,997 cases 117
Breath tests with stable isotopes: have they a role in liver transplantation? 116
DIAGNOSTIC ACCURACY OF LIVER AND SPLEEN STIFFNESS MEASUREMENT FOR PORTAL HYPERTENSION USING BIDIMENSIONAL SHEAR WEAVE ELASTOGRAPHY 116
Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review 116
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant: Results of an open, uncontrolled multicenter study 116
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 115
null 115
Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study 115
Non-invasive diagnostic approach to non-alcoholic fatty liver disease: Current evidence and future perspectives 114
Bacteria flora,gas and antibiotics 114
Dietary Management in IBS Patients 113
Ductal stones recurrence after extracorporeal shock wave lithotripsy for difficult common bile duct stones: Predictive factors 113
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 113
Simultaneous Analysis of SEPT9 Promoter Methylation Status, Micronuclei Frequency, and Folate-Related Gene Polymorphisms: The Potential for a Novel Blood-Based Colorectal Cancer Biomarker 113
HCV infection is a risk factor for gallstone disease in liver cirrhosis: An Italian epidemiological survey 113
Proton pump inhibitors in cirrhosis: tradition or evidence based practice? 112
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients 112
null 111
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease. 111
Pharmacological modulation of MRP2 in primary biliary cirrhosis 110
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 110
Curcumin and fennel essential oil improve symptoms and quality of life in patients with irritable bowel syndrome 110
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation variant. Result of an open, uncontrolled , multicenter trial. 109
Prognostic factors for hepatocellular carcinoma recurrence 108
P.09.6 IL28 POLYMORPHISM AND HCC DEVELOPMENT AFTER DAAS FOR CHRONIC HEPATITIS C 108
Noninvasive Assessment of Portal Hypertension in Advanced Chronic Liver Disease: An Update 108
Gut microbiota and its pathophysiology in disease paradigms. 108
Nerve fiber overgrowth in patients with symptomatic diverticular disease 108
Efficacy of ursodeoxycholic acid administration on clinical manifestations of gallstones and gastrointestinal motility 107
Liver and Spleen Stiffness Measurements for Assessment of Portal Hypertension Severity in Patients with Budd Chiari Syndrome 107
Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly 107
Micronucleus frequency in human peripheral blood lymphocytes as a biomarker for the early detection of colorectal cancer risk. 105
Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon 105
Interleukin 28 polymorphisms and hepatocellular carcinoma development after direct acting antiviral therapy for chronihepatitis c 105
Micronuclei frequency in peripheral blood lymphocytes as biomarker for colorectal cancer risk. 104
Gut microbiota and metabolic syndrome. 104
null 104
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 104
Hypertransaminasemia and pregnancy outcome. 103
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 103
MALDI-TOF MS protein profiling using selective extraction with derivatized cellulose and chemometric analysis: from hepatitis C to hepatocellular carcinoma 102
A new point-of-care portable immunosensor for non-invasive assessment of oro-ileal transit time by oral fluid tauroursodeoxycholate measurement after its oral load. 102
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 102
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project). 101
Totale 12.870
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.432
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.432
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.284 0 0 0 0 0 550 640 675 635 317 175 292
2020/20213.007 544 178 82 178 110 140 87 183 306 161 122 916
2021/20224.816 343 172 246 271 402 218 113 251 170 247 1.674 709
2022/20234.494 484 603 254 568 314 359 125 234 834 104 351 264
2023/20241.454 71 232 109 152 109 394 71 72 70 76 50 48
2024/20252.975 207 864 507 333 914 150 0 0 0 0 0 0
Totale 23.798